Nerve Repair and Regeneration Market
The global Nerve Repair and Regeneration Market Size was valued at $6.6 billion in 2020 and is projected to reach $12.3 billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030. fueled by rising neurological disorders and geriatric populations. Key segments include neurostimulation/neuromodulation devices and biomaterials like nerve conduits/wraps.
Market Drivers and Trends
- Rising Disease Prevalence: Increasing incidents of neurological diseases (Alzheimer’s, Parkinson’s) and traumatic injuries are driving market demand.
- Technological Advancements: Growth is supported by advancements in bioelectronic medicine, 3D-bioprinted nerve grafts, and AI-enabled neurostimulation.
- Key Segments: Neurostimulation/neuromodulation devices currently hold the largest share, while stem cell therapy is expected to witness rapid growth.
- Regional Dominance: North America leads the market due to high healthcare expenditure, established players, and high prevalence of neurological disorders.
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.alliedmarketresearch.com/request-sample/299
Major determinants of the market growth
Rise in prevalence of neurological & epidemic disorders and surge in geriatric population that need nerve repair and regeneration therapy drive the global nerve repair and regeneration market. However, high cost associated with neurostimulator devices and lack of skilled professionals hinder the market growth. On the contrary, surge in awareness among people and increase in expenditure on healthcare would open new opportunities in the future.
The biomaterials segment to manifest the highest CAGR through 2030
By product, the biomaterials segment is expected to showcase the highest CAGR of 7.0% during the forecast period, due to increase in target population base and increase in awareness among patients. However, the neuromodulation surgery devices segment held the largest share in 2020, contributing to more than two-thirds of the global nerve repair and regeneration market, owing to increase in consumer awareness about nerve repair and advent of innovative technologies in the healthcare sector.
You can place an order or ask any questions, please feel free to contact us at: https://www.alliedmarketresearch.com/purchase-enquiry/299
The neuromodulation surgery segment held the lion’s share
By surgery, the neuromodulation surgery segment dominated the market in terms of revenue, accounting for nearly half of the global nerve repair and regeneration market in 2020, due to rise in number of product approvals. However, the direct neuropathy segment would portray the highest CAGR of 7.6% during the forecast period, due to surge in awareness of benefits of using external neuromodulators.
North America held the largest share
By region, the global nerve repair and regeneration market across North America held the lion’s share in 2020, contributing to around two-fifths of the market, due to increase in the prevalence of neurodegenerative & neurodevelopmental diseases, stroke, and traumatic brain injuries coupled with increase in adoption of advanced healthcare infrastructure. However, the market across Asia-Pacific is projected to manifest the highest CAGR of 7.5% during the forecast period, owing to rise in awareness among patient, supportive government initiatives, and presence of unmet medical needs, and advent of innovative technologies.
Get the latest insights on life science industry segmentation with our Annual Membership: https://www.alliedmarketresearch.com/nerve-repair-regeneration-market/purchase-options
Market Challenges
- High Costs: Expensive treatment procedures, including specialized nerve stimulation devices and surgeries, hinder market access.
- Regulatory Hurdles: Stringent regulations for product approvals act as a barrier to market entry and growth.
- Specialist Shortage: A lack of skilled professionals for complex nerve procedures limits adoption in certain regions.
Key market players
- Abbott Laboratories
- Integra Lifesciences Corporation
- Boston scientific Inc.
- Axogenic
- Medtronic plc
- Checkpoint Surgical
- Stryker Corporation
- Synovis Micro Companies Alliance
- Polyganics
- OrthoMed, Inc.
Related Reports:
Immune Checkpoint Inhibitors Market From USD 40.1 Billion in 2022 to USD 189.4 Billion by 2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail themselves of an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. Each data presented in the reports published by us is extracted through primary interviews with top officials from leading companies in the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
